171 related articles for article (PubMed ID: 22418755)
1. Crystalluria.
van Noord C; Wulkan RW; van den Dorpel MA
Neth J Med; 2012 Mar; 70(2):84, 87. PubMed ID: 22418755
[No Abstract] [Full Text] [Related]
2. [Severe acute bronchitis].
Gillissen A
MMW Fortschr Med; 2009 Aug; 151(34-35):49-50. PubMed ID: 19771793
[No Abstract] [Full Text] [Related]
3. [Management of community-acquired pneumopathies of adults in the city and at the hospital].
Léophonte P
Presse Med; 1998 Sep; 27 Suppl 4():5-7. PubMed ID: 9798473
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
5. An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.
Lin TY; Lin SM; Chen HC; Wang CJ; Wang YM; Chang ML; Wang CH; Liu CY; Lin HC; Yu CT; Hsieh LL; Kuo HP; Huang CD
Chang Gung Med J; 2007; 30(4):321-32. PubMed ID: 17939262
[TBL] [Abstract][Full Text] [Related]
6. Erythema multiforme following antibiotic therapy for pneumonia.
Peng CZ; How CK
QJM; 2013 Jun; 106(6):585-6. PubMed ID: 22690011
[No Abstract] [Full Text] [Related]
7. [Community acquired pneumonia].
Marrie TJ
Praxis (Bern 1994); 2001 May; 90(21):935-40. PubMed ID: 11512537
[No Abstract] [Full Text] [Related]
8. The efficacy and safety of amoxicillin-clavulanic acid 1000/125mg twice daily extended release (XR) tablet for the treatment of bacterial community-acquired pneumonia in adults.
Prabhudesai PP; Jain S; Keshvani A; Kulkarni KP
J Indian Med Assoc; 2011 Feb; 109(2):124-7. PubMed ID: 21888181
[TBL] [Abstract][Full Text] [Related]
9. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
Yakovlev SV; Suvorova MP
Antibiot Khimioter; 1997; 42(10):23-8. PubMed ID: 9412399
[No Abstract] [Full Text] [Related]
10. Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different?
Mandell L
Clin Infect Dis; 2008 May; 46(10):1522-4. PubMed ID: 18419485
[No Abstract] [Full Text] [Related]
11. Guidelines for the management of community-acquired pneumonia in children.
Lee PI; Chiu CH; Chen PY; Lee CY; Lin TY;
Acta Paediatr Taiwan; 2007; 48(4):167-80. PubMed ID: 18265536
[No Abstract] [Full Text] [Related]
12. [Efficacy and tolerability of pristinamycin vs amoxicillin-clavulanic acid combination in the treatment of acute community-acquired pneumonia in hospitalized adults].
Poirier R; Chardon H; Beraud A; Debieuvre D; Petitprez P; Montestruc F; Lilienthal F; Janus C
Rev Pneumol Clin; 1997; 53(6):325-31. PubMed ID: 9616826
[TBL] [Abstract][Full Text] [Related]
13. [High mortality. Elderly pneumonia patients need aggressive therapy].
Stiefelhagen P
MMW Fortschr Med; 2008 Oct; 150(43):15. PubMed ID: 19031578
[No Abstract] [Full Text] [Related]
14. [Initial empirical antibiotic treatment of community-acquired pneumonia].
Frías J; Gomis M; Prieto J; Mensa J; Bouza E; García-Rodríguez JA; Torres A; Dorca J; Zalacaín R; García de Lomas J
Rev Esp Quimioter; 1998 Sep; 11(3):255-61. PubMed ID: 9795313
[No Abstract] [Full Text] [Related]
15. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitor-protected aminopenicillins. Pharmacological characterization and role in community-acquired infections].
Guchev IA; Melekhina EV
Antibiot Khimioter; 2009; 54(7-8):56-65. PubMed ID: 20201405
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.
Fernández-Sabé N; Carratalà J; Dorca J; Rosón B; Tubau F; Manresa F; Gudiol F
Eur J Clin Microbiol Infect Dis; 2003 Mar; 22(3):185-7. PubMed ID: 12649717
[TBL] [Abstract][Full Text] [Related]
18. Acute psychosis caused by co-amoxiclav.
Bell CL; Watson B; Waring WS
BMJ; 2008 Oct; 337():a2117. PubMed ID: 18945734
[No Abstract] [Full Text] [Related]
19. Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
Batard E; Javaudin F; Kervagoret E; Caruana E; Le Bastard Q; Chapelet G; Goffinet N; Montassier E
Clin Microbiol Infect; 2018 Nov; 24(11):1171-1176. PubMed ID: 29964229
[TBL] [Abstract][Full Text] [Related]
20. BTS guidelines for the management of community acquired pneumonia in adults: update 2009.
Lim WS; Baudouin SV; George RC; Hill AT; Jamieson C; Le Jeune I; Macfarlane JT; Read RC; Roberts HJ; Levy ML; Wani M; Woodhead MA;
Thorax; 2009 Oct; 64 Suppl 3():iii1-55. PubMed ID: 19783532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
